This webinar provides information about the funding opportunity announcements, Leveraging Cognitive Neuroscience Research to Improve Assessment of Cancer Treatment Related Cognitive Impairment. These announcements have been reissued as PAR-18-605 (R01 Clinical Trial Optional). National Cancer Institute Program Director and Senior Scientist, Dr. Jerry Suls, provides an overview.
September 14, 2016
September 24, 2020